- 現金殖利率: N/A、總殖利率: 9.09%、5年平均現金配發率: 99.23%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 (10) | -0.66 | 0 | 0.00 | 0 | 1.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2023 (9) | -1.13 | 0 | 1.00 | 100.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (8) | 0.66 | -74.42 | 0.50 | -66.67 | 0.00 | 0 | 75.76 | 30.3 | 0.00 | 0 | 75.76 | 30.3 |
| 2021 (7) | 2.58 | -84.72 | 1.50 | -85.0 | 0.00 | 0 | 58.14 | -1.86 | 0.00 | 0 | 58.14 | -1.86 |
| 2020 (6) | 16.88 | 2457.58 | 10.00 | 400.0 | 0.00 | 0 | 59.24 | -80.45 | 0.00 | 0 | 59.24 | -80.45 |
| 2019 (5) | 0.66 | 100.0 | 2.00 | 300.0 | 0.00 | 0 | 303.03 | 100.0 | 0.00 | 0 | 303.03 | 100.0 |
| 2018 (4) | 0.33 | 6.45 | 0.50 | 66.67 | 0.00 | 0 | 151.52 | 56.57 | 0.00 | 0 | 151.52 | 56.57 |
| 2017 (3) | 0.31 | -63.1 | 0.30 | -40.0 | 0.00 | 0 | 96.77 | 62.58 | 0.00 | 0 | 96.77 | 62.58 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 25Q2 (20) | -0.51 | -13.33 | -466.67 | -0.11 | 80.0 | 56.0 | -0.96 | -113.33 | -174.29 |
| 25Q1 (19) | -0.45 | -275.0 | -73.08 | -0.55 | -120.0 | -14.58 | -0.45 | 31.82 | -73.08 |
| 24Q4 (18) | -0.12 | 36.84 | 68.42 | -0.25 | -25.0 | 7.41 | -0.66 | -22.22 | 41.59 |
| 24Q3 (17) | -0.19 | -111.11 | 17.39 | -0.20 | 20.0 | 60.0 | -0.54 | -54.29 | 28.0 |
| 24Q2 (16) | -0.09 | 65.38 | 50.0 | -0.25 | 47.92 | 0.0 | -0.35 | -34.62 | 32.69 |
| 24Q1 (15) | -0.26 | 31.58 | 21.21 | -0.48 | -77.78 | -33.33 | -0.26 | 76.99 | 21.21 |
| 23Q4 (14) | -0.38 | -65.22 | -850.0 | -0.27 | 46.0 | -440.0 | -1.13 | -50.67 | -271.21 |
| 23Q3 (13) | -0.23 | -27.78 | -154.76 | -0.50 | -100.0 | -354.55 | -0.75 | -44.23 | -207.14 |
| 23Q2 (12) | -0.18 | 45.45 | -185.71 | -0.25 | 30.56 | -56.25 | -0.52 | -57.58 | -285.71 |
| 23Q1 (11) | -0.33 | -725.0 | -571.43 | -0.36 | -620.0 | -125.0 | -0.33 | -150.0 | -571.43 |
| 22Q4 (10) | -0.04 | -109.52 | -113.33 | -0.05 | 54.55 | -125.0 | 0.66 | -5.71 | -74.62 |
| 22Q3 (9) | 0.42 | 100.0 | 2200.0 | -0.11 | 31.25 | -57.14 | 0.70 | 150.0 | -69.57 |
| 22Q2 (8) | 0.21 | 200.0 | -74.39 | -0.16 | 0.0 | -113.79 | 0.28 | 300.0 | -87.93 |
| 22Q1 (7) | 0.07 | -76.67 | -95.33 | -0.16 | -180.0 | -111.03 | 0.07 | -97.31 | -95.33 |
| 21Q4 (6) | 0.30 | 1600.0 | -87.23 | 0.20 | 385.71 | -92.34 | 2.60 | 13.04 | -84.71 |
| 21Q3 (5) | -0.02 | -102.44 | -100.5 | -0.07 | -106.03 | -101.65 | 2.30 | -0.86 | -84.31 |
| 21Q2 (4) | 0.82 | -45.33 | 0.0 | 1.16 | -20.0 | 0.0 | 2.32 | 54.67 | 0.0 |
| 21Q1 (3) | 1.50 | -36.17 | 0.0 | 1.45 | -44.44 | 0.0 | 1.50 | -91.18 | 0.0 |
| 20Q4 (2) | 2.35 | -40.95 | 0.0 | 2.61 | -38.59 | 0.0 | 17.01 | 16.03 | 0.0 |
| 20Q3 (1) | 3.98 | 0.0 | 0.0 | 4.25 | 0.0 | 0.0 | 14.66 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0.44 | 44.3 | 23.45 | 2.66 | 0.78 | 1.06 | N/A | - | ||
| 2025/7 | 0.3 | -6.27 | -12.63 | 2.23 | -2.7 | 0.97 | N/A | - | ||
| 2025/6 | 0.32 | -7.27 | 5.43 | 1.92 | -0.94 | 1.01 | 4.41 | - | ||
| 2025/5 | 0.35 | 2.3 | 6.14 | 1.6 | -2.13 | 1.05 | 4.24 | - | ||
| 2025/4 | 0.34 | -6.45 | -21.41 | 1.26 | -4.19 | 0.95 | 4.71 | - | ||
| 2025/3 | 0.36 | 48.69 | 15.55 | 0.92 | 4.26 | 0.92 | 5.39 | - | ||
| 2025/2 | 0.24 | -21.2 | 1.42 | 0.55 | -2.0 | 1.09 | 4.53 | - | ||
| 2025/1 | 0.31 | -42.38 | -4.55 | 0.31 | -4.55 | 1.18 | 4.2 | - | ||
| 2024/12 | 0.54 | 62.69 | 43.59 | 4.21 | 0.48 | 1.19 | 4.1 | - | ||
| 2024/11 | 0.33 | 1.21 | -4.44 | 3.67 | -3.74 | 1.03 | 4.76 | - | ||
| 2024/10 | 0.33 | -12.11 | 4.77 | 3.34 | -3.67 | 1.05 | 4.66 | - | ||
| 2024/9 | 0.37 | 5.28 | 23.04 | 3.01 | -4.51 | 1.07 | 4.64 | - | ||
| 2024/8 | 0.35 | 2.12 | 7.9 | 2.64 | -7.42 | 1.0 | 4.94 | - | ||
| 2024/7 | 0.35 | 13.11 | 6.74 | 2.29 | -9.41 | 0.98 | 5.07 | - | ||
| 2024/6 | 0.31 | -6.64 | -0.64 | 1.94 | -11.78 | 1.06 | 4.63 | - | ||
| 2024/5 | 0.33 | -24.26 | 8.06 | 1.64 | -13.59 | 1.07 | 4.6 | - | ||
| 2024/4 | 0.43 | 37.54 | 33.13 | 1.31 | -17.7 | 0.99 | 5.0 | - | ||
| 2024/3 | 0.31 | 30.51 | -7.88 | 0.88 | -30.7 | 0.88 | 5.79 | - | ||
| 2024/2 | 0.24 | -25.84 | -34.39 | 0.56 | -39.09 | 0.94 | 5.42 | - | ||
| 2024/1 | 0.32 | -13.32 | -42.16 | 0.32 | -42.16 | 1.04 | 4.88 | - | ||
| 2023/12 | 0.37 | 8.26 | -16.16 | 4.18 | -25.87 | 1.03 | 4.89 | - | ||
| 2023/11 | 0.35 | 10.98 | -21.85 | 3.81 | -26.7 | 0.96 | 5.26 | - | ||
| 2023/10 | 0.31 | 3.2 | -22.34 | 3.47 | -27.15 | 0.94 | 5.36 | - | ||
| 2023/9 | 0.3 | -7.66 | -26.32 | 3.15 | -27.59 | 0.95 | 5.68 | - | ||
| 2023/8 | 0.33 | 1.02 | -35.0 | 2.85 | -27.72 | 0.96 | 5.65 | - | ||
| 2023/7 | 0.32 | 5.27 | -46.63 | 2.53 | -26.66 | 0.93 | 5.8 | - | ||
| 2023/6 | 0.31 | 1.54 | -48.95 | 2.2 | -22.4 | 0.93 | 5.73 | - | ||
| 2023/5 | 0.3 | -6.69 | -58.33 | 1.89 | -15.25 | 0.97 | 5.53 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2023/4 | 0.32 | -4.83 | 713.06 | 1.59 | 5.45 | 1.03 | 5.19 | 本月營收較去年同期增加,主係去年同期生產基地昆山熱映因配合當地政府新冠肺炎防疫措施停工停產導致去年同期基期偏低所致 | ||
| 2023/3 | 0.34 | -7.04 | -32.43 | 1.27 | -13.73 | 1.27 | 4.42 | - | ||
| 2023/2 | 0.37 | -34.63 | -11.59 | 0.93 | -3.97 | 1.37 | 4.08 | - | ||
| 2023/1 | 0.56 | 25.64 | 1.74 | 0.56 | 1.74 | 1.45 | 3.86 | - | ||
| 2022/12 | 0.45 | 0.91 | -28.05 | 5.65 | -42.68 | 1.29 | 4.5 | - | ||
| 2022/11 | 0.44 | 10.29 | -26.73 | 5.2 | -43.67 | 1.25 | 4.63 | - | ||
| 2022/10 | 0.4 | -2.08 | -24.45 | 4.76 | -44.85 | 1.31 | 4.42 | - | ||
| 2022/9 | 0.41 | -18.54 | -18.58 | 4.36 | -46.19 | 1.52 | 3.93 | - | ||
| 2022/8 | 0.5 | -17.04 | 0.33 | 3.95 | -48.02 | 1.71 | 3.48 | - | ||
| 2022/7 | 0.61 | 0.69 | 0.22 | 3.44 | -51.43 | 1.93 | 3.08 | 本年累計較去年同期減少,主係因出貨量減少所致 | ||
| 2022/6 | 0.6 | -17.1 | -20.95 | 2.84 | -56.25 | 1.37 | 4.25 | 本年累計較去年同期減少,主係因出貨量減少所致 | ||
| 2022/5 | 0.73 | 1720.66 | -19.75 | 2.24 | -60.94 | 1.27 | 4.57 | 本年累計較去年同期減少,主係因出貨量減少所致 | ||
| 2022/4 | 0.04 | -92.09 | -96.03 | 1.51 | -68.68 | 0.96 | 6.06 | 本月營收較去年同期減少,主係生產基地昆山熱映因配合當地政府新冠肺炎防疫措施,停工停產,4月份九成以上訂單遞延至5月出貨 | ||
| 2022/3 | 0.5 | 21.62 | -51.04 | 1.47 | -61.47 | 1.47 | 4.12 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2022/2 | 0.41 | -24.76 | -60.56 | 0.97 | -65.33 | 1.59 | 3.82 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2022/1 | 0.55 | -11.16 | -68.22 | 0.55 | -68.22 | 1.78 | 3.41 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/12 | 0.62 | 2.77 | -69.98 | 9.85 | -62.35 | 1.75 | 3.23 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/11 | 0.6 | 13.72 | -77.9 | 9.23 | -61.7 | 1.64 | 3.46 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/10 | 0.53 | 5.52 | -79.66 | 8.63 | -59.62 | 1.53 | 3.69 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/9 | 0.5 | 0.38 | -79.15 | 8.1 | -56.84 | 1.61 | 3.44 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/8 | 0.5 | -17.13 | -77.28 | 7.59 | -53.54 | 1.87 | 2.97 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/7 | 0.6 | -20.58 | -78.43 | 7.09 | -49.84 | 2.27 | 2.44 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/6 | 0.76 | -15.85 | -72.05 | 6.49 | -42.77 | 2.67 | 1.94 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/5 | 0.9 | -9.97 | -64.83 | 5.73 | -33.5 | 2.94 | 1.77 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/4 | 1.01 | -2.41 | -52.33 | 4.82 | -20.14 | 3.09 | 1.68 | 本月較去年同期減少,主係因出貨量減少所致 | ||
| 2021/3 | 1.03 | -2.04 | -49.36 | 3.82 | -2.87 | 3.82 | 1.39 | - | ||
| 2021/2 | 1.05 | -39.36 | -15.51 | 2.79 | 47.03 | 4.85 | 1.09 | - | ||
| 2021/1 | 1.73 | -16.1 | 166.81 | 1.73 | 166.81 | 6.53 | 0.81 | 本公司體溫量測相關產品供應全球新冠肺炎防疫所需，帶動企業營收成長。 | ||
| 2020/12 | 2.07 | -24.31 | 223.66 | 26.17 | 233.37 | 7.41 | 0.74 | 本公司體溫量測相關產品供應全球新冠肺炎防疫所需，帶動企業營收成長。 | ||
| 2020/11 | 2.73 | 4.64 | 288.57 | 24.1 | 234.23 | 7.75 | 0.71 | 本公司體溫量測相關產品供應全球新冠肺炎防疫所需，海外市場需求強勁，帶動企業營收成長。 | ||
| 2020/10 | 2.61 | 8.15 | 317.67 | 21.37 | 228.36 | 0.0 | N/A | 本公司體溫量測相關產品供應全球新冠肺炎防疫所需，海外市場需求強勁，帶動企業營收成長。 | ||
| 2020/9 | 2.41 | 9.41 | 218.11 | 18.76 | 218.87 | 0.0 | N/A | 本公司體溫量測相關產品供應全球新冠肺炎防疫所需，海外市場需求強勁，帶動企業營收成長。 |